- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Wall Street JournalEN
V
VTRS
Viatris Inc Ord Shs
8.34
0.09+1.09%After Hours: 8.35 +0.01 +0.12%19:38 04/29 EDT
OPEN/PREV CLOSE8.15/8.25
TODAY RANGE8.12-8.44
VOL13.22M
MARKET CAP9.96B
52 WEEK RANGE6.85-13.38
AVG VOL (3M)14.60M
% TURNOVER1.11%
TURNOVER--
P/E (TTM)-15.6914
% RANGE3.88%
EPS(TTM)-0.5315
P/E(FORWARD)-56.3323
P/B0.5342
BVPS15.61
DIVIDEND0.4800
P/S0.6754
BETA--
DIV YIELD5.76%
FREE FLOAT MKT CAP9.90B
SHARES OUTSTANDING1.19B
NEXT EARNINGS--
FREE FLOAT1.19B
LOT SIZE1
EX-DIV DATE03/10/2025
News
Press Releases
Financial Reports
Profile
TipRanks·20h ago
Piper Sandler Sticks to Its Hold Rating for Viatris (VTRS)
Seeking Alpha·1d ago
Viatris on track to close seventh straight session of gains
Seeking Alpha·4d ago
Biogen: Is This A Value Trap, Or Is The Great Turnaround Imminent?
TipRanks·04/21 13:41
Viatris price target lowered to $8 from $10 at BofA
Benzinga·04/21 12:25
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
TipRanks·04/21 12:22
Bank of America Securities Keeps Their Sell Rating on Viatris (VTRS)
TipRanks·04/21 11:05
Viatris files Effexor supplemental new drug applications to Japan MHLW
Dow Jones·04/14 10:59
Press Release: Viatris Appoints Hemanth J. Varghese as Chief Strategy Officer
Seeking Alpha·04/09 18:26
Pharma, MedTech stocks bounce back as Trump pauses tariffs
Seeking Alpha·04/09 11:03
Bristol-Myers gets Pomalyst antitrust case dismissed
The Motley Fool·04/09 08:22
3 Beaten-Down Stocks That Are Trading Below Their Book Values
Same Industry
Name/Symbol
Change%
Price